To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Leonard Green in $270m exit
Two and a half years after investing $100m into Phoenix Scientific, the Los Angeles private equity firm has agreed to sell the manufacturer of animal pharmaceuticals for approximately $270m in cash and stock to industry player IVAX.
